Zymeworks (ZYME) Short-term Investments (2021 - 2026)

Zymeworks has disclosed Short-term Investments across 6 years of filings, most recently posting $120.4 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $120.4 million, down 36.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $120.4 million (down 36.3% YoY), and the FY2025 annual result was $187.6 million, up 17.52% from the prior year.
• Short-term Investments came in at $120.4 million for Q1 2026 at Zymeworks, down from $187.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $259.2 million in Q2 2024 to a low of $70.2 million in Q3 2022.
• The 5-year median for Short-term Investments is $187.1 million (2025), against an average of $175.2 million.
• Across the five-year window, Short-term Investments jumped 186.59% in 2023 and slumped 36.3% in 2026, its largest moves.
• Zymeworks' Short-term Investments stood at $91.3 million in 2022, then soared by 137.37% to $216.8 million in 2023, then decreased by 26.34% to $159.7 million in 2024, then climbed by 17.52% to $187.6 million in 2025, then plunged by 35.81% to $120.4 million in 2026.
• The last three Short-term Investments figures came in at $120.4 million (Q1 2026), $187.6 million (Q4 2025), and $187.1 million (Q3 2025), per Business Quant data.